maintenance_mode
TL3 Regular · Christchurch, NZ
Maintenance dosing, lowest effective dose, and the awkward question of how long is long enough.
Joined 12 October 2024 · last posted 3d
140 posts, newest first. Showing up to 150.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #101 · Data & Tools › Datasets · 24 Jul 2026 · 0 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
How shortages have affected compounding permissions Replied, post #52 · Access › Shortages · 19 Jul 2026 · 23 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Immortal time bias in a claims-database study — one year on Replied, post #32 · Evidence › Study critique · 19 Jul 2026 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #16 · Analytics › Impurities & related substances · 19 Jul 2026 · 31 likes post #15 answers the question as asked. The question underneath it is different. Deletion sequences (incomplete coupling during synthesis): lower in mass by one…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #67 · Evidence › Journal club · 16 Jul 2026 · 5 likes This follows post #64 rather than contradicting it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #107 · Devices › Syringes & needles · 15 Jul 2026 · 10 likes post #106 is right about the mechanism and I think understates the practical bit. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1…
-
Journal club: what we got wrong in an earlier session Replied, post #81 · Evidence › Journal club · 13 Jul 2026 · 21 likes Picking up post #78: that is the part I would want checked first. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
-
How shortages have affected compounding permissions Replied, post #16 · Access › Shortages · 5 Jul 2026 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 5 Jul 2026 · 6 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
How much context is too much context in a first post? Replied, post #9 · marked as the solution · Start Here › How to Ask · 4 Jul 2026 · 24 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #98 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 12 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #39 · Analytics › Impurities & related substances · 1 Jul 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Prescription requirements and telehealth models — a second dataset Replied, post #83 · Sourcing › Regulatory · 28 Jun 2026 · 30 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #48 · Compounds › Repair & healing peptides · 25 Jun 2026 · 26 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
About the Receptor biology category Replied, post #6 · Pharmacology › Receptor biology · 24 Jun 2026 · 0 likes post #5 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #127 · Practice › Reconstitution · 24 Jun 2026 · 0 likes Worth separating two things that post #123 runs together. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose"…
-
Submitting a sample: the process end to end Replied, post #35 · Sourcing › Independent verification · 24 Jun 2026 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Sleep quality changes during weight loss Replied, post #49 · Wellbeing › Sleep · 20 Jun 2026 · 1 like Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #11 · Clinical › Bloodwork · 15 Jun 2026 · 1 like I read post #9 twice before replying, because I had assumed the opposite. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #23 · Compounds › Secretagogues & GH axis · 14 Jun 2026 · 26 likes This follows post #20 rather than contradicting it. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose…
-
Revisiting: What pooling buys you and what it destroys Replied, post #52 · Evidence › Meta-analyses · 12 Jun 2026 · 23 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Racemisation and why it is invisible to a mass measurement Replied, post #40 · Analytics › Impurities & related substances · 10 Jun 2026 · 3 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Historical amylin analogues and what happened to them Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 9 Jun 2026 · 2 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #26 · Compounds › Secretagogues & GH axis · 7 Jun 2026 · 4 likes On post #22 — agreed on the reasoning, with one qualification. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this…
-
Reading a trial's population section before its results Replied, post #83 · Evidence › Trials · 3 Jun 2026 · 0 likes post #82 answers the question as asked. The question underneath it is different. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Injecting into an area that has become firm: why not to Replied, post #7 · Practice › Administration · 2 Jun 2026 · 6 likes Coming back to post #5, because the follow-up matters more than the original answer. Injection discomfort: comes from needle gauge (finer = less discomfort), volume…
-
The anatomy of a question that gets answered within an hour Replied, post #59 · Start Here › How to Ask · 28 May 2026 · 0 likes This follows post #56 rather than contradicting it. What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #52 · Meta › Announcements · 24 May 2026 · 3 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Publication patterns in the BPC-157 literature, examined Started this topic · Compounds › Repair & healing peptides · 20 May 2026 · 3 likes Posting this under the heading it deserves: Publication patterns in the BPC-157 literature, examined Everything below is what sits behind that. I have seen SURPASS-2 (…
-
What a certificate commits its issuer to — the long version Replied, post #8 · Analytics › COA interpretation · 19 May 2026 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #5 · Compounds › Secretagogues & GH axis · 12 May 2026 · 5 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #45 · Sourcing › Independent verification · 10 May 2026 · 1 like How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #35 · Compounds › Tirzepatide · 9 May 2026 · 30 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Micro-titration: a disputed topic, argued properly Replied, post #66 · Practice › Dosing & titration · 27 Apr 2026 · 4 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Second pass at: Why chargeback is not the safety net people assume Replied, post #2 · Sourcing › Payments · 20 Apr 2026 · 16 likes the opening post answers the question as asked. The question underneath it is different. Fraud and scams: if a supplier demands payment upfront with no recourse if…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #21 · Clinical › Bloodwork · 13 Apr 2026 · 31 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Choosing which test to pay for, given a fixed budget Replied, post #61 · Sourcing › Independent verification · 9 Apr 2026 · 0 likes post #60 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #59 · Data & Tools › Calculators · 9 Apr 2026 · 29 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #38 · Practice › Administration · 31 Mar 2026 · 27 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #16 · Meta › Announcements · 14 Mar 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #18 · Compounds › Repair & healing peptides · 9 Mar 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Waist circumference technique and its repeatability Replied, post #61 · Outcomes › Progress reports · 9 Mar 2026 · 9 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #13 · Analytics › Impurities & related substances · 5 Mar 2026 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Deletion sequences (incomplete coupling during synthesis): lower in mass by one…
-
Coming back to: Time to steady state after a dose increase Replied, post #8 · Pharmacology › Pharmacokinetics · 2 Mar 2026 · 0 likes Picking up post #5: that is the part I would want checked first. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That…
-
Choosing which test to pay for, given a fixed budget Replied, post #10 · Sourcing › Independent verification · 1 Mar 2026 · 18 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Coming back to: Swirling versus inverting versus leaving it alone Started this topic · Practice › Reconstitution · 25 Feb 2026 · 18 likes Swirling versus inverting versus leaving it alone Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #76 · Outcomes › Progress reports · 17 Feb 2026 · 4 likes Picking up post #73: that is the part I would want checked first. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #6 · Meta › Announcements · 17 Feb 2026 · 0 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #25 · Compounds › Semaglutide · 11 Feb 2026 · 24 likes Coming back to post #23, because the follow-up matters more than the original answer. Is there a ceiling dose beyond which the effect plateaus? The trials did not study…
-
Dead volume across syringe and needle combinations Replied, post #69 · Devices › Syringes & needles · 9 Feb 2026 · 7 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #78 · Pharmacology › Pharmacokinetics · 8 Feb 2026 · 17 likes Coming back to post #76, because the follow-up matters more than the original answer. Albumin binding: semaglutide binds albumin through a fatty side chain, which…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #17 · Clinical › Comorbidities · 7 Feb 2026 · 5 likes post #16 is right about the mechanism and I think understates the practical bit. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #78 · Access › Pricing · 2 Feb 2026 · 1 like Worth separating two things that post #74 runs together. Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Started this topic · Pharmacology › Formulation chemistry · 29 Jan 2026 · 0 likes On the subject in the title: Solubility limits and what a cloudy solution is telling you Working notes rather than a conclusion. A documentation question rather than an…
-
Revisiting: Absolute versus relative contraindications Replied, post #12 · Safety › Contraindications · 22 Jan 2026 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #57 · Analytics › Method validation · 22 Jan 2026 · 12 likes Coming back to post #55, because the follow-up matters more than the original answer. Range: the concentration range over which the method has been validated. Going…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #42 · Clinical › Bloodwork · 2 Jan 2026 · 7 likes I read post #40 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #45 · Pharmacology › Pharmacokinetics · 25 Dec 2025 · 9 likes Worth separating two things that post #41 runs together. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
-
Prescription requirements and telehealth models Replied, post #81 · Sourcing › Regulatory · 21 Dec 2025 · 17 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Request: export my own posts — one year on Replied, post #24 · Meta › Feature requests · 19 Dec 2025 · 6 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Early satiety becoming a problem rather than a benefit Replied, post #16 · Practice › Side effects · 15 Dec 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tracking that stops updating and then resumes — the long version Replied, post #47 · Sourcing › Logistics · 5 Dec 2025 · 16 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #27 · Access › Pricing · 1 Dec 2025 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Coverage in the US: a map of the usual obstacles Replied, post #16 · Regional › North America · 28 Nov 2025 · 2 likes Coming back to post #14, because the follow-up matters more than the original answer. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are…
-
Second pass at: Programming during a large energy deficit Replied, post #101 · Nutrition & Training › Resistance training · 28 Nov 2025 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #143 · Start Here › How to Ask · 25 Nov 2025 · 0 likes Picking up post #140: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Thyroid function tests during substantial weight change Replied, post #143 · Clinical › Bloodwork · 21 Nov 2025 · 0 likes Coming back to post #141, because the follow-up matters more than the original answer. A single value outside interval: usually uninformative on a single draw. What…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #51 · Compounds › Semaglutide · 20 Nov 2025 · 4 likes This follows post #48 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Pen dose counters: what a click does and does not guarantee Replied, post #91 · Devices › Pens & autoinjectors · 18 Nov 2025 · 2 likes Worth separating two things that post #87 runs together. Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to…
-
[2026 update] What steady state means for the decision to escalate Replied, post #83 · Practice › Dosing & titration · 13 Nov 2025 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading SURMOUNT-1 without the press release Replied, post #53 · Compounds › Tirzepatide · 2 Nov 2025 · 0 likes Worth separating two things that post #49 runs together. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #95 · Devices › Cold chain · 26 Oct 2025 · 0 likes post #94 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Waist circumference technique and its repeatability Replied, post #10 · Outcomes › Progress reports · 25 Oct 2025 · 16 likes This follows post #7 rather than contradicting it. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity…
-
Insurance and replacement policies, compared — the long version Replied, post #29 · Sourcing › Logistics · 21 Oct 2025 · 30 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #53 · Pharmacology › Receptor biology · 16 Oct 2025 · 6 likes post #52 answers the question as asked. The question underneath it is different. Central versus peripheral action: GLP-1 agonism works through both central nervous…
-
What a purity-only report leaves out Replied, post #38 · Sourcing › Independent verification · 7 Oct 2025 · 9 likes This follows post #35 rather than contradicting it. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks…
-
What pooling buys you and what it destroys Replied, post #33 · Evidence › Meta-analyses · 1 Oct 2025 · 19 likes Picking up post #30: that is the part I would want checked first. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population,…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #59 · Compounds › Other compounds · 30 Sep 2025 · 11 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
A preprint whose numbers changed substantially at publication Replied, post #59 · Evidence › Preprints · 19 Sep 2025 · 13 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #46 · Analytics › Method validation · 12 Sep 2025 · 1 like Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Reading SURMOUNT-1 without the press release Replied, post #6 · Compounds › Tirzepatide · 10 Sep 2025 · 0 likes Worth separating two things that post #2 runs together. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #92 · Data & Tools › Datasets · 9 Sep 2025 · 8 likes I read post #90 twice before replying, because I had assumed the opposite. Collection methods: ask how the data were collected. Longitudinal tracking over months is…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #71 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes post #70 is right about the mechanism and I think understates the practical bit. Bias toward positive outcomes: datasets collected by members are biased toward people…
-
Travel coolers and how long they really hold Replied, post #82 · Devices › Cold chain · 8 Aug 2025 · 3 likes Coming back to post #80, because the follow-up matters more than the original answer. Travel with medication: carrying a vial across borders requires planning if…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #101 · Compounds › Tirzepatide · 6 Aug 2025 · 23 likes This follows post #98 rather than contradicting it. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see…
-
How to research a compound with no human data without deceiving yourself Replied, post #83 · Compounds › Other compounds · 3 Aug 2025 · 0 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #67 · Sourcing › Regulatory · 2 Aug 2025 · 2 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
When a preprint is the best available evidence and we say so Replied, post #12 · Evidence › Preprints · 31 Jul 2025 · 1 like How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
System suitability injections: if they failed, the run did not happen Replied, post #18 · Analytics › HPLC & UHPLC · 29 Jul 2025 · 27 likes post #17 answers the question as asked. The question underneath it is different. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
-
Insomnia at a dose step: reported experiences Started this topic · Wellbeing › Sleep · 16 Jul 2025 · 4 likes On the subject in the title: Insomnia at a dose step: reported experiences Working notes rather than a conclusion. General question, not a request for advice about my…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #86 · Compounds › Tirzepatide · 12 Jul 2025 · 1 like post #85 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Repeatability versus intermediate precision Replied, post #133 · Analytics › Method validation · 3 Jul 2025 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
EU-wide position versus national implementation Replied, post #15 · Regional › European Union · 3 Jul 2025 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #43 · Compounds › Repair & healing peptides · 18 Jun 2025 · 0 likes Worth separating two things that post #39 runs together. Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #85 · Practice › Reconstitution · 13 Jun 2025 · 30 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
"Should I double up?" — answered once, at length, calmly Replied, post #2 · Practice › Administration · 11 Jun 2025 · 1 like A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Half-life, steady state, and accumulation worked through Replied, post #22 · Pharmacology › Pharmacokinetics · 25 May 2025 · 28 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
A claim built entirely on a subgroup analysis Replied, post #54 · Evidence › Study critique · 25 May 2025 · 3 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #22 · Analytics › Mass spectrometry · 23 May 2025 · 4 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #33 · Compounds › Oral incretins · 17 May 2025 · 0 likes Worth separating two things that post #29 runs together. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #94 · Sourcing › Independent verification · 14 May 2025 · 23 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
A report I filed that turned out to be wrong, and the correction Replied, post #46 · Sourcing › Vendor reports · 9 May 2025 · 16 likes Picking up post #43: that is the part I would want checked first. Disputed records: when a result disagreed and was not explained, the record says disputed and stays…
-
A supplier that answers analytical questions with restated claims Replied, post #65 · Sourcing › Red flags · 27 Apr 2025 · 0 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Reading an MS report that only gives you a single number Replied, post #54 · Analytics › Mass spectrometry · 16 Apr 2025 · 0 likes This follows post #51 rather than contradicting it. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not…
-
When "no data" is the complete and final answer Replied, post #136 · Compounds › Other compounds · 2 Apr 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #44 · Analytics › Mass spectrometry · 24 Mar 2025 · 29 likes post #43 answers the question as asked. The question underneath it is different. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #9 · Evidence › Journal club · 23 Mar 2025 · 2 likes Picking up post #6: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #90 · Analytics › COA interpretation · 16 Mar 2025 · 22 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #134 · Sourcing › Regulatory · 5 Mar 2025 · 10 likes post #133 is right about the mechanism and I think understates the practical bit. Approval versus licensing: a compound can be approved for a specific indication in one…
-
UK access routes, dated and sourced — a second dataset Replied, post #45 · Regional › UK & Ireland · 2 Mar 2025 · 15 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
Reading an MS report that only gives you a single number Replied, post #18 · Analytics › Mass spectrometry · 27 Feb 2025 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Validating a method you did not develop — does this still hold? Replied, post #24 · Analytics › Method validation · 19 Feb 2025 · 0 likes This follows post #21 rather than contradicting it. Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by…
-
Distinguishing a deletion sequence by mass alone Replied, post #99 · Analytics › Mass spectrometry · 17 Feb 2025 · 16 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
What we do not know about retatrutide, listed explicitly Replied, post #84 · Compounds › Retatrutide · 5 Feb 2025 · 18 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Protein density versus volume when you cannot eat much Replied, post #46 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 4 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Recovery when intake is low: what to cut first Replied, post #66 · Nutrition & Training › Resistance training · 13 Jan 2025 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #2 · Clinical › Bloodwork · 8 Jan 2025 · 24 likes the opening post is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #19 · Practice › Interactions · 3 Jan 2025 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #2 · Sourcing › Red flags · 1 Jan 2025 · 17 likes On the opening post — agreed on the reasoning, with one qualification. Safety documentation absent: a supplier that cannot provide information about sterility testing,…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #19 · Evidence › Journal club · 28 Dec 2024 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #2 · Clinical › Bloodwork · 27 Dec 2024 · 15 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #10 · Evidence › Meta-analyses · 25 Dec 2024 · 20 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #78 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes This follows post #75 rather than contradicting it. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no…
-
A vial that will not fully dissolve: what to check and in what order Replied, post #8 · marked as the solution · Practice › Reconstitution · 21 Dec 2024 · 9 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #78 · Access › Insurance & coverage · 20 Dec 2024 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #120 · Practice › Dosing & titration · 6 Dec 2024 · 31 likes Picking up post #117: that is the part I would want checked first. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #68 · Compounds › Tirzepatide · 30 Nov 2024 · 2 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Revisiting: Moderation log format change Replied, post #47 · Meta › Announcements · 29 Nov 2024 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #50 · Meta › Wiki maintenance · 28 Nov 2024 · 0 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
-
Fixed versus detachable needles: the trade-offs Replied, post #20 · Devices › Syringes & needles · 26 Nov 2024 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
EMA product information as a primary source — does this still hold? Replied, post #22 · Regional › European Union · 15 Nov 2024 · 0 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #56 · Compounds › Repair & healing peptides · 14 Nov 2024 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #26 · Sourcing › Regulatory · 11 Nov 2024 · 22 likes This follows post #23 rather than contradicting it. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market…
-
Time to steady state after a dose increase Replied, post #137 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #23 · Clinical › Prescriber conversations · 1 Nov 2024 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #13 · Sourcing › Regulatory · 25 Oct 2024 · 1 like post #12 answers the question as asked. The question underneath it is different. Off-label use and medical practice: clinicians can prescribe approved medications…
-
Promotion criteria, and the one that stops most nominations Replied, post #67 · Documentation › Doc review · 22 Sep 2024 · 27 likes Worth separating two things that post #63 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #18 · Clinical › Bloodwork · 9 Sep 2024 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Micronutrient status when intake falls substantially — a second dataset Started this topic · Clinical › Bloodwork · 29 Jul 2024 · 0 likes Micronutrient status when intake falls substantially — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Asking about…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #86 · Practice › Dosing & titration · 9 Jul 2024 · 6 likes On post #82 — agreed on the reasoning, with one qualification. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose…